CME Group (NASDAQ:CME – Free Report) had its price target lifted by Keefe, Bruyette & Woods from $237.00 to $260.00 in a research note released on Friday,Benzinga reports. They currently have a market perform rating on the financial services provider’s stock.
Several other equities research analysts have also commented on CME. Barclays upped their price target on shares of CME Group from $231.00 to $257.00 and gave the company an “equal weight” rating in a report on Monday, December 9th. Deutsche Bank Aktiengesellschaft lowered their target price on CME Group from $227.00 to $226.00 and set a “hold” rating on the stock in a research note on Monday, November 11th. The Goldman Sachs Group lifted their price target on CME Group from $195.00 to $198.00 and gave the company a “sell” rating in a research report on Thursday, October 3rd. Royal Bank of Canada restated a “sector perform” rating and issued a $235.00 price objective on shares of CME Group in a research report on Thursday, October 24th. Finally, Piper Sandler lifted their target price on shares of CME Group from $240.00 to $250.00 and gave the company an “overweight” rating in a report on Monday, October 28th. Four research analysts have rated the stock with a sell rating, seven have issued a hold rating and four have issued a buy rating to the company’s stock. Based on data from MarketBeat.com, CME Group currently has a consensus rating of “Hold” and a consensus target price of $229.33.
Check Out Our Latest Research Report on CME Group
CME Group Trading Up 0.7 %
CME Group (NASDAQ:CME – Get Free Report) last posted its quarterly earnings results on Wednesday, October 23rd. The financial services provider reported $2.68 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.65 by $0.03. The company had revenue of $1.58 billion during the quarter, compared to analyst estimates of $1.59 billion. CME Group had a net margin of 57.34% and a return on equity of 13.39%. CME Group’s revenue for the quarter was up 18.4% compared to the same quarter last year. During the same period last year, the firm posted $2.25 EPS. Equities analysts predict that CME Group will post 10.22 EPS for the current year.
CME Group declared that its Board of Directors has authorized a share buyback plan on Thursday, December 5th that authorizes the company to repurchase $3.00 billion in outstanding shares. This repurchase authorization authorizes the financial services provider to repurchase up to 3.4% of its shares through open market purchases. Shares repurchase plans are generally a sign that the company’s management believes its stock is undervalued.
CME Group Increases Dividend
The business also recently announced a dividend, which will be paid on Thursday, January 16th. Stockholders of record on Friday, December 27th will be paid a dividend of $5.80 per share. The ex-dividend date is Friday, December 27th. This is a boost from CME Group’s previous dividend of $2.50. CME Group’s payout ratio is currently 48.37%.
Insider Buying and Selling
In other news, insider Timothy Francis Mccourt sold 1,374 shares of CME Group stock in a transaction that occurred on Monday, October 28th. The shares were sold at an average price of $227.12, for a total transaction of $312,062.88. Following the sale, the insider now owns 7,275 shares of the company’s stock, valued at approximately $1,652,298. The trade was a 15.89 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Sunil Cutinho sold 4,500 shares of the stock in a transaction that occurred on Wednesday, October 30th. The stock was sold at an average price of $226.64, for a total value of $1,019,880.00. Following the completion of the transaction, the insider now owns 27,053 shares of the company’s stock, valued at $6,131,291.92. The trade was a 14.26 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders have sold 7,274 shares of company stock worth $1,648,071. Insiders own 0.30% of the company’s stock.
Hedge Funds Weigh In On CME Group
Several large investors have recently modified their holdings of CME. Harbor Capital Advisors Inc. raised its position in CME Group by 0.6% in the third quarter. Harbor Capital Advisors Inc. now owns 7,810 shares of the financial services provider’s stock valued at $1,723,000 after purchasing an additional 45 shares during the period. CVA Family Office LLC grew its stake in shares of CME Group by 11.8% in the third quarter. CVA Family Office LLC now owns 436 shares of the financial services provider’s stock valued at $96,000 after buying an additional 46 shares in the last quarter. Lester Murray Antman dba SimplyRich raised its holdings in shares of CME Group by 0.7% in the 2nd quarter. Lester Murray Antman dba SimplyRich now owns 7,667 shares of the financial services provider’s stock valued at $1,507,000 after buying an additional 50 shares during the period. Zions Bancorporation N.A. lifted its stake in CME Group by 3.7% during the 3rd quarter. Zions Bancorporation N.A. now owns 1,530 shares of the financial services provider’s stock worth $338,000 after acquiring an additional 54 shares in the last quarter. Finally, Quent Capital LLC boosted its holdings in CME Group by 10.2% during the 3rd quarter. Quent Capital LLC now owns 593 shares of the financial services provider’s stock valued at $131,000 after acquiring an additional 55 shares during the period. Institutional investors and hedge funds own 87.75% of the company’s stock.
About CME Group
CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.
Featured Stories
- Five stocks we like better than CME Group
- Health Care Stocks Explained: Why You Might Want to Invest
- Oil Titans Face Off: Exxon Mobil or Chevron for 2025 Gains?
- 5 Top Rated Dividend Stocks to Consider
- Mining Stocks Back in the Spotlight: 3 Key Names to Watch
- 3 Stocks to Consider Buying in October
- MarketBeat Week in Review – 12/16 – 12/20
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.